基因檢測市場：按類型、疾病、技術和地區分類

Genetic Testing Market, By Type, By Disease, By Technology, By Geography

出版日期: 2026年03月26日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，基因檢測市場規模將達到291.7億美元，2033年將達到669.5億美元。預計從2026年到2033年，該市場將以12.6%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	291.7億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	12.60%	2033年市場規模預測：	669.5億美元

基因檢測是一種醫學檢測，用於識別基因、染色體或蛋白質的變異。基因檢測結果有助於確定個體是否患有疑似遺傳疾病，排除患病可能性，並評估個體患有遺傳疾病或將其遺傳給後代的風險。基因檢測在醫療保健的許多領域都發揮著重要作用，並有可能徹底改變人們接受醫療服務的方式。

市場動態

遺傳和罕見疾病負擔日益加重、基因檢測在腫瘤領域的應用不斷擴大、基因檢測的廣泛應用、對個性化醫療的高需求以及對直接面對消費者 (DTC) 基因檢測日益成長的需求，預計將成為推動全球基因檢測市場在預測期內成長的主要促進因素。

例如，2022 年 6 月，基因組學和診斷測試領域的領導企業之一 Prenetics Group Limited 宣布推出 ColoClear by Circle（ColoClear），這是一種突破性的非侵入性家庭篩檢測試，用於檢測結直腸癌的早期徵兆。

此外，基因組定序公司Illumina於2022年3月在歐洲推出了一項癌症檢測，可從單一組織樣本中檢測多種腫瘤基因。預計這將提高罕見疾病患者找到合適治療方法的幾率。

本研究的關鍵特徵

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司亮點、產品系列、主要特點、財務績效和策略等參數，創建了全球基因檢測市場主要參與者的概況。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球基因檢測市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球基因檢測市場中使用的各種策略矩陣輕鬆做出決策。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 29.17 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.60%	2033 Value Projection:	USD 66.95 Bn

Genetic testing is a type of medical test that identifies changes in genes, chromosomes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Genetic testing is useful in many areas of medicine and can change the medical care people receives.

Market Dynamics

Rise in burden of genetic and rare disorders, increasing application of genetic testing in oncology, growing applications of genetic testing, high demand for personalized medicine, and increasing demand for direct-to-consumer genetic testing are major factors expected to augment the growth of the global genetic testing market over the forecast period.

For instance, in June 2022, Prenetics Group Limited, one of the leaders in genomic and diagnostic testing, introduced a novel, non-invasive at-home screening test, ColoClear by Circle (ColoClear), for detecting early signs of colorectal cancer.

Moreover, in March 2022, Illumina, a genome sequencing group, launched a cancer test in Europe that checks for a wide range of tumor genes in one tissue sample, potentially helping patients with rare diseases to be matched up with treatment options.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global genetic testing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include 23&Me Inc., Qiagen NV, Eurofins Scientific, PerkinElmer Inc., Illumina Inc., Danaher Corporation, Myriad Genetics Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, BioRad Laboratories Inc., and DiaSorin S.p.A. (Luminex Corporation), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global genetic testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genetic testing market.

Market Segmentation

Type Insights (Revenue, USD Bn, 2026 - 2033)
Carrier Testing
Diagnostic Testing
New-born Screening
Predictive and Presymptomatic Testing
Prenatal Testing
Other Types
Disease Insights (Revenue, USD Bn, 2026 - 2033)
Alzheimer's Disease
Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular Dystrophy
Thalassemia
Huntington's Disease
Rare Diseases
Other Diseases
Technology Insights (Revenue, USD Bn, 2026 - 2033)
Cytogenetic Testing
Biochemical Testing
Molecular Testing
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Key Players Insights
23&Me Inc.
Qiagen NV
Eurofins Scientific
PerkinElmer Inc.
Illumina Inc.
Danaher Corporation
Myriad Genetics Inc.
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Quest Diagnostics Incorporated
BioRad Laboratories Inc.
DiaSorin S.p.A. (Luminex Corporation)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Disease
- Market Snapshot, By Technology
- Market Genetic Testing, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rise in burden of genetic/rare disorders
- High cost of genetic testing
- Growing applications of genetic testing
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Genetic Testing Market, By Type, 2022-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Carrier Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Diagnostic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
New-born Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Predictive and Presymptomatic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Prenatal Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Other Types
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)

5. Global Genetic Testing Market, By Disease, 2022-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Sickle Cell Anemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Duchenne Muscular Dystrophy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Thalassemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Huntington's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Other Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)

6. Global Genetic Testing Market, By Technology, 2022-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cytogenetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Biochemical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
Molecular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)

7. Global Genetic Testing Market, By Geography, 2022-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)

8. Competitive Landscape

23&Me Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Qiagen NV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Myriad Genetics Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioRad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DiaSorin S.p.A. (Luminex Corporation)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views